Lexaria Bioscience CorpNASDAQ:LEXX
- LAST PRICE3.3800
- TODAY'S CHANGE (%)0.2900 (9.3851%)
- Bid / Lots3.2200/ 1
- Ask / Lots3.3800/ 7
- Open / Previous Close3.1000 / 3.0900
- Day Range
- 52 Week Range
- Volume201,516
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LEXX |
|---|---|---|
| 09:32 ET | 16640 | 3.2284 |
| 09:34 ET | 8558 | 3.3 |
| 09:36 ET | 100 | 3.37 |
| 09:38 ET | 6355 | 3.29 |
| 09:39 ET | 2413 | 3.1409 |
| 09:41 ET | 6298 | 3.3024 |
| 09:43 ET | 1896 | 3.3 |
| 09:45 ET | 4036 | 3.24 |
| 09:48 ET | 3900 | 3.1 |
| 09:56 ET | 500 | 3.2059 |
| 10:01 ET | 4358 | 3.19 |
| 10:03 ET | 1054 | 3.2104 |
| 10:06 ET | 250 | 3.2999 |
| 10:10 ET | 1100 | 3.2357 |
| 10:12 ET | 10021 | 3.122 |
| 10:15 ET | 3990 | 3.05 |
| 10:26 ET | 492 | 3.2134 |
| 10:33 ET | 800 | 3.18 |
| 10:35 ET | 502 | 3.14 |
| 10:37 ET | 8184 | 3.13 |
| 10:48 ET | 646 | 3.1999 |
| 11:00 ET | 3900 | 3.08 |
| 11:08 ET | 100 | 3.1389 |
| 11:15 ET | 5914 | 3.09 |
| 11:24 ET | 1000 | 3.15 |
| 11:38 ET | 200 | 3.15 |
| 11:49 ET | 1558 | 3.16 |
| 11:54 ET | 500 | 3.1686 |
| 11:58 ET | 2295 | 3.21 |
| 12:02 ET | 2000 | 3.195 |
| 12:09 ET | 4976 | 3.15 |
| 12:12 ET | 11513 | 3.185 |
| 12:18 ET | 300 | 3.17 |
| 12:23 ET | 486 | 3.2 |
| 12:34 ET | 338 | 3.204 |
| 12:36 ET | 286 | 3.183 |
| 12:38 ET | 1000 | 3.1801 |
| 12:39 ET | 285 | 3.18 |
| 12:50 ET | 3375 | 3.2106 |
| 12:57 ET | 333 | 3.17 |
| 01:24 ET | 3100 | 3.18 |
| 01:28 ET | 400 | 3.173 |
| 01:32 ET | 320 | 3.197 |
| 01:39 ET | 1100 | 3.18 |
| 01:42 ET | 1000 | 3.1801 |
| 02:02 ET | 1993 | 3.23 |
| 02:04 ET | 10115 | 3.36 |
| 02:09 ET | 100 | 3.2701 |
| 02:13 ET | 919 | 3.27 |
| 02:15 ET | 1387 | 3.2703 |
| 02:18 ET | 1190 | 3.27 |
| 02:20 ET | 242 | 3.295 |
| 02:22 ET | 500 | 3.3035 |
| 02:31 ET | 300 | 3.3 |
| 02:33 ET | 2000 | 3.272 |
| 02:42 ET | 200 | 3.27 |
| 02:45 ET | 500 | 3.24 |
| 02:47 ET | 100 | 3.27 |
| 02:56 ET | 1380 | 3.27 |
| 02:58 ET | 300 | 3.27 |
| 03:02 ET | 100 | 3.3308 |
| 03:05 ET | 2006 | 3.3199 |
| 03:09 ET | 210 | 3.33 |
| 03:21 ET | 500 | 3.2901 |
| 03:23 ET | 5006 | 3.36 |
| 03:25 ET | 833 | 3.2998 |
| 03:27 ET | 600 | 3.29 |
| 03:30 ET | 300 | 3.33 |
| 03:32 ET | 100 | 3.29 |
| 03:36 ET | 100 | 3.3 |
| 03:38 ET | 1500 | 3.33 |
| 03:39 ET | 800 | 3.33 |
| 03:41 ET | 2025 | 3.34 |
| 03:43 ET | 1000 | 3.3401 |
| 03:45 ET | 5000 | 3.3699 |
| 03:48 ET | 1414 | 3.38 |
| 03:50 ET | 3887 | 3.41 |
| 03:52 ET | 100 | 3.3801 |
| 03:54 ET | 500 | 3.4 |
| 03:56 ET | 3142 | 3.3515 |
| 03:57 ET | 310 | 3.35 |
| 03:59 ET | 314 | 3.38 |
Jul 18, 2024
DJ Lexaria Bioscience Price Target Maintained With a $10.00/Share by HC Wainwright & Co., from 12:50PM ET on Thursday Jul 18, 2024 by Dow Jones
12:50PM ET on Thursday Jul 18, 2024 by Dow Jones
Jul 17, 2024
Positive Interim Body Weight Results from Lexaria's Diabetes Animal Study, from 10:40AM ET on Wednesday Jul 17, 2024 by Dow Jones
10:40AM ET on Wednesday Jul 17, 2024 by Dow Jones
Jul 16, 2024
Lexaria Preparing For Strategic Growth, from 9:21AM ET on Tuesday Jul 16, 2024 by Dow Jones
9:21AM ET on Tuesday Jul 16, 2024 by Dow Jones
Jul 10, 2024
DJ Lexaria Bioscience Initiated at Buy by HC Wainwright & Co., from 6:57AM ET on Wednesday Jul 10, 2024 by Dow Jones
6:57AM ET on Wednesday Jul 10, 2024 by Dow Jones
Jul 9, 2024
Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study, from 9:14AM ET on Tuesday Jul 09, 2024 by Dow Jones
9:14AM ET on Tuesday Jul 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Lexaria Bioscience Corp | 48.9M | -7.6x | --- |
Odonate Inc | 50.0M | -1,254.8x | --- |
Bright Green Corp | 45.0M | -3.7x | --- |
KALA BIO Inc | 32.3M | -0.5x | --- |
China Health Industries Holdings Inc | 30.2M | -22.2x | --- |
Cyclo Therapeutics Inc | 32.0M | -1.1x | --- |
Company Information
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.
Contact Information
- Headquarters
- 100 - 740 MCCURDY ROADKELOWNA, BC, Canada V1X 2P7
- Phone
- 250-765-6424
- Fax
- 604-685-7602
Executives
- Chairman of the Board, Chief Executive Officer, Principal Financial Officer
- Christopher Bunka
- President, Director
- John Docherty
- Independent Director
- Nicholas Baxter
- Independent Director
- Ted Mckechnie
- Independent Director
- Albert Reese
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $48.9M |
|---|---|
Revenue (TTM) | $411.0K |
Shares Outstanding | 15.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.01 |
EPS | $-0.45 |
Book Value | $0.38 |
P/E Ratio | -7.6x |
Price/Sales (TTM) | 118.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,185.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
